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Adipokines, including adiponectin and leptin, are secreted by adipose tissue. With 
an increase in fat mass, concentrations of adiponectin decrease and leptin increase, 
altering the adiponectin/leptin (A/L) ratio. A/L ratio is associated with metabolic 
dysfunction, as are multiple diet factors including breastfeeding in infancy and breakfast 
intake. However, it is not known whether these diet factors are related to A/L ratio, and if 
they will protect against metabolic dysfunction in a population at an increased risk. The 
purpose of this study was to investigate whether breastfeeding duration in infancy and 
current breakfast frequency are associated with A/L ratio and metabolic dysfunction in 
children and adolescents with obesity. 
The study cohort consisted of obese (body mass index ≥ 95th percentile) children 
and adolescents (n = 100, 46M). Fasting blood samples were taken to measure high 
density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, insulin, 
glucose, adiponectin, and leptin levels. Weight, height, and blood pressure were also 
assessed. Breastfeeding history was obtained through the National Health and Nutrition 
Examination Survey of 2003-2004, and breakfast frequency was reported through the 
Gold Medal School Parent Questionnaire administered to parents.  
Of the 100 participants, 82% were breastfed as infants. Among the breastfed, 66% 
(n = 54) were breastfed for ≥ 6 months and 62% (n = 54) were breastfed exclusively for  
≥ 6 months (4 parents could not recall duration of exclusive breastfeeding). Of the 
 breakfast responses collected (n = 46), most participants (59%, n = 27) reported 
consuming breakfast every day. There was no association between these diet factors and 
A/L ratio or the presence of metabolic dysfunction. Differences in A/L (p = 0.02) and 
leptin (p = 0.009) were noted between categorical breakfast frequencies when gender was 
controlled for, and there was a significant difference in BMI between categorical 
breakfast intakes (p = 0.02). There were no significant relationships in the linear model of 
breakfast. No association between A/L ratio and metabolic dysfunction was observed. In 
conclusion, breastfeeding duration and breakfast frequency do not appear to influence 
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The prevalence of obese children and adolescents (age 2-19) in the United States 
has almost tripled since 1980, with nearly 17% of this age group obese as of 2009 (1). 
Obesity, particularly central obesity, is one risk factor for metabolic syndrome in adults 
(2) and children (3). Metabolic syndrome is characterized by a cluster of risk factors that, 
when occurring simultaneously, increase the risk of chronic diseases such as type II 
diabetes, coronary artery disease, and stroke. In adults, the syndrome is well defined (2); 
however, consensus is lacking over the appropriate manner to define and diagnose 
metabolic syndrome in youth (4).  
In children, markers of metabolic dysfunction, especially those relating to 
cardiovascular disease (CVD) and insulin resistance, may be used to determine risk of the 
above chronic diseases in lieu of a metabolic syndrome diagnosis (4). Markers of 
metabolic dysfunction include dyslipidemia (decreased high density lipoprotein 
cholesterol [HDL], elevated low density lipoprotein cholesterol [LDL], and elevated 
triglycerides), elevated blood pressure, insulin resistance (4), and elevated waist to height 
ratio (WHR) (5). A number of factors have been associated with an altered risk of 
metabolic dysfunction. LDL cholesterol has been observed to decrease with a greater 
consumption of monounsaturated (6) and polyunsaturated fatty acids (7), as well as with 
a greater intake of nuts (8); the Dietary Approaches to Stop Hypertension (DASH) diet, 
along with a daily 500 calorie restriction, may increase HDL and decrease triglycerides 
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and blood pressure (9); a high intake of fiber may lower insulin and postprandial glucose 
levels (10, 11); and daily consumption of sugar sweetened beverages has been associated 
with an increased risk of metabolic syndrome, elevated blood pressure, high triglycerides, 
and low HDL (12). Serum adiponectin, leptin, and diet factors such as breastfeeding in 
infancy and breakfast intake are also known to influence metabolic dysfunction risk. 
Adiponectin and leptin are two adipokines that have been linked to metabolic 
health. These adipokines are produced and secreted by adipose tissue (13); however, as 
the amount of white adipose tissue increases, serum adiponectin concentration decreases 
(14) while leptin increases (15). In adolescents, an inverse relationship has been observed 
between adiponectin and triglycerides, systolic blood pressure, and WHR, along with a 
positive relationship to HDL levels, regardless of body mass index (BMI) (16). In adults, 
high adiponectin levels appear to protect against insulin resistance and heart disease (17, 
18), while low levels are associated with dyslipidemia, elevated blood pressure, type II 
diabetes, and coronary artery disease (17, 19). 
Blood concentrations of leptin and adiponectin can also be measured as a ratio to 
predict risk of metabolic dysfunction using the A/L ratio. Low adiponectin and high 
leptin levels (a low A/L ratio) may be a predictor of atherosclerosis in healthy adult males 
(20) and has been related to a greater risk of CVD and the associated risk factors in both 
adults and children (21, 22, 23). A low A/L ratio has been correlated with the presence of 
metabolic syndrome (24, 25, 26, 27), and has been observed to be a better predictor of 
insulin resistance than HOMA-IR or adiponectin and leptin levels alone (28, 29). 
Infant nutrition, particularly breastfeeding, may also influence risk of metabolic 
disease later in life. Research suggests that the risk of chronic disease, such as type II 
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diabetes and CVD, is lower if an individual was breastfed during infancy (4, 30, 31, 32, 
33). A history of breastfeeding may promote a lower cholesterol and BMI in adulthood 
(4), and the World Health Organization concluded that a longer duration is associated 
with lower total cholesterol, blood pressure, and prevalence of overweight or obesity 
(33).  
Additionally, the consumption of a daily breakfast is a dietary pattern that can 
impact risk of disease and metabolic dysfunction in adolescence. Evidence supports an 
inverse relationship between frequent breakfast intake and overweight/obesity (34, 35, 
36). A history of skipping breakfast throughout life has been linked to markers of 
metabolic dysfunction that include elevated waist circumference, fasting insulin, total 
cholesterol, LDL, and decreased HDL (37, 38). In children and adolescents with obesity, 
skipping meals (primarily breakfast) may also be associated with higher fasting glucose 
and triglycerides (39).  
A history of breastfeeding and regular breakfast consumption appear to be 
beneficial in minimizing metabolic dysfunction, but additional research is necessary. For 
example, breastfeeding has been negatively associated with obesity in some studies (40, 
41, 42), while in others the results were slight or not statistically significant (43, 44). 
Contradicting results were also observed between breastfeeding and HDL (40, 45), LDL, 
triglycerides, and blood pressure (45). Similarly, while breakfast has been associated with 
a healthy weight (34, 35, 36), a large cross sectional analysis of breakfast consumption in 
Korean adolescents found no correlation between frequency of breakfast intake and body 
weight (46). Finally, little research has been conducted on the benefits of a history of 
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breastfeeding and breakfast intake in those at increased risk of metabolic dysfunction, 
namely, children who are already obese. 
Although A/L ratio and diet have individually been found to modify risk of 
metabolic dysfunction, it is not known if diet and A/L ratio are associated. Research 
supports an association between diet and adiponectin levels, including a positive 
association with greater consumption of fiber and low glycemic index foods (47), whole 
grains (48), a higher score on the Healthy Eating Index  (49), and adherence to the 
Mediterranean diet (48, 50). Negative associations were noted with greater refined cereal 
consumption (51). Investigations into dietary habits like breastfeeding and breakfast 
consumption, however, are limited. Most literature on breastfeeding is focused on 
adiponectin concentrations between different breastfeeding durations in infants. In 
addition, there has been only one study suggesting that consuming an early meal (such as 
breakfast) may beneficially influence serum adiponectin in obese individuals for at 
least 3 hours (52).  
Further research is needed to clarify the relationship between diet, A/L ratio and 
metabolic dysfunction, and to determine if diet and A/L ratio are linked. Specifically, 
little is known about the impact infant breastfeeding and breakfast consumption may have 
on A/L ratio in the pediatric obese. The aim of this study was to investigate the 
relationship between dietary factors (including breastfeeding duration and breakfast 
frequency) and A/L ratio in a cohort of obese children and adolescents. In addition, this 
study explored the degree that these dietary factors and A/L ratio influence metabolic 








This cross sectional study examined the relationship between diet, the 
adiponectin/leptin (A/L) ratio, and metabolic dysfunction during puberty in obese (BMI  
> 95
th
 percentile for age and gender) children and adolescents age 8-17 years. The 
specific dietary measures collected include a history of breastfeeding duration in infancy 
and current average frequency of breakfast intake. Diet was evaluated through the use of 
questions from validated questionnaires. Serum lipids, insulin, glucose, adiponectin and 
leptin were collected via fasted blood draw. Degree of metabolic dysfunction was 
determined using serum lipids (HDL, LDL, and triglycerides), blood pressure, insulin 
resistance (HOMA-IR), and WHR. Participants were enrolled between the period of July 
15, 2010 and January 31, 2013.  
Participants were recruited from Salt Lake County in the following venues: as 
family members of a research cohort of extremely obese adults (followed by Dr. Steve 
Hunt, Cardiovascular Genetics Center, University of Utah), the University of Utah 
Adolescent Preventive Cardiology Clinic (APCC), the University Pediatrics Clinic, 
community pediatric healthcare providers, public buildings, wellness facilities, the 
Catholic Diocese, and universities and colleges in Salt Lake County. Enrollment in the 
study occurred following informed parental consent and child assent. After informed 
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consent was completed, baseline data was collected. This study protocol was approved by 
the University of Utah Institutional Review Board for Human Subjects (IRB#31720). 
 
Subject Selection Criteria 
 
Obese (BMI ≥ 95th percentile for age and gender) children and adolescents 
(n=100), both male (n=46) and female (n=54), between the ages of 8 and 17 at the time of 
recruitment, were eligible for this study. Participants were required to be in good health 
other than insulin resistance, dyslipidemia, impaired glucose tolerance, or hypertension. 
Exclusion criteria included refusal to participate, an inability to speak either English or 
Spanish, a genetic syndrome or other endocrine disorder known to cause obesity 
(Cushing’s, Prader Willi, leptin deficiency, etc.), hypothyroidism, cystic fibrosis, history 
of pregnancy, cancer or history of cancer, active infectious disease, a history of 
cardiovascular disease or stroke during the previous 36 months, triglycerides > 400 
mg/dL, diabetes mellitus (types I and II), and the use of  psychotropics, sulphonylureas, 
thiazolidinediones, insulin, glucocorticoids, antineoplastic agents, angiotensin receptor 
blocker, or angiotensin converting enzyme inhibitors.  
 
Screening Process 
Patients were identified from the APCC and the University Pediatrics Clinic by 
chart review or by a pediatrician. All potential participants were assessed for inclusion 
and exclusion criteria over the phone using a standardized instrument. Participants who 
qualified were then invited to schedule an appointment at the Center for Clinical and 
Translational Science (CCTS), Oquirrh View Community Health Center, or St. Joseph 




Height was measured to the nearest 0.1 cm with a stadiometer (Model Height-Rite 
225, Seca, Culver City, CA). Waist circumference was obtained by wrapping a measuring 
tape around the torso at the level of the umbilicus. The measurement was recorded at the 
end of expiration while the tape was held snugly without compressing the skin. Height 
and waist circumference were each taken twice; if the difference between the two 
measurements was greater than 1 cm, a third measurement was performed and an average 
of measurements was used. Waist circumference and height were used to calculate the 
WHR. Weight was obtained using a digital scale (Model 5002, Scale-Tronix, White 
Plains, NY). BMI was calculated as kg/m
2
. Blood pressure was measured two times in 
one arm using a sphygmomanometer (Model Dynamap Pro 400, GE, Fairfield, CT). If 
the difference between the measurements was greater than 5 mmHg, a third measurement 
was performed and an average of the measurements was used. All measurements were 
obtained by a trained research assistant. 
 
Biomarkers 
Blood draws were obtained from participants following an overnight fast of at 
least 12 hours via standard CCTS procedures. Specifically, an intravenous catheter was 
placed in the arm to collect blood for measurement of fasting serum concentrations of 
insulin, glucose, adiponectin, leptin, and a complete lipid profile.  
Insulin, adiponectin, and leptin concentrations in sera were measured in an 
enzyme linked immunosorbent assay format by Dr. Cynthia Chappell at the University of 
Texas at Houston using commercially available kits (Alpco Diagnostics, Salem, 
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NH). These kits have intraassay precision of 1.0 – 7.4% and interassay precision of 2.4 – 
8.4%. The sensitivity of the assays is 1.5 ng/mL; accuracy is     92 – 100%. Procedures 
for each assay were carried out according to the manufacturer’s instructions. Each serum 
sample was assayed twice.  All concentrations were derived from a standard curve run on 
the same plate.  Samples exceeding the highest concentration of the standard curve were 
diluted 1:2 and reassayed in duplicate. Standard curves for all plates yielded an R
2
 value 
of ≥0.98. The coefficient of variation for TC and triglycerides are <2%, and <5% for 
HDL (53). LDL was calculated using the Friedwald equation. Lipid analysis was 
performed in the Cardiovascular Genetics Research Center Laboratory using a manual 
method (colorimetric for TC and triglycerides, dextran sulfate precipitation method for 
HDL). Glucose was measured using a glucose analyzer. Serum adiponectin and leptin 
were used to calculate the A/L ratio. Insulin and glucose were used to calculate HOMA-
IR (an estimate of insulin resistance).  
 
Metabolic Dysfunction 
Metabolic dysfunction was defined as the presence of at least three abnormal 
measurements of lipids, blood pressure, insulin sensitivity, or WHR. Specific cutoffs for 
measurements included, HDL ≤ 40 mg/dL, LDL ≥ 110 mg/dL, triglycerides ≥ 75 mg/dL 
for children 9 years of age and younger and ≥ 90 mg/dL for children age 10 and up, blood 
pressure  ≥ 90th percentile or > 120/80 mmHg (4), HOMA-IR ≥ 3.16 (54), and a WHR 







Breastfeeding History and Dietary Intake 
Nutrition history was obtained after the blood draw. The participant or the 
parent/guardian completed a paper copy of the nutrition questionnaire while a research 
assistant was present to answer questions. Breastfeeding history was reported via 
questions from the National Health and Nutrition Examination Survey Diet Behavior and 
Nutrition Survey of 2003-2004 (57). Parents reported breastfeeding history through 
survey questions regarding the child’s age at first food  or beverage other than breast milk 
(exclusive breastfeeding duration) and age at complete cessation of breastfeeding (total 
breastfeeding duration). If breastfeeding history questions were missed during the 
scheduled appointment, the parent/guardian was contacted by a trained research assistant 
by phone or email to collect the missing data. The average days per week the participant 
consumes breakfast was obtained using questions from the Gold Medal School Parent 
Questionnaire (Appendix) (58). 
 
Statistical Analysis 
Means and standard deviations of lipids, blood pressure, insulin, glucose, 
adiponectin, leptin, A/L ratio, history of breastfeeding duration, and breakfast frequency 
were computed. A generalized linear model was used to model BMI, adiponectin, leptin, 
and A/L ratio in terms of breastfeeding duration (both total and exclusive) and breakfast 
frequency while also controlling for ethnicity and gender. Fisher’s F-test was applied to 
check if the presence and duration of breastfeeding and breakfast intake were 
significantly related to BMI, adiponectin, leptin, and A/L ratio. Breakfast frequency was 
also treated as categorical data and analysis of variance was applied.  
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Logistic regression was applied to predict the presence of metabolic dysfunction 
(with ≥ 3 and ≥ 4 abnormal measures) using breastfeeding, breakfast intake, and A/L 
ratio as predictors. Chi-square tests were applied to test if these predictors had a 
significant relationship with metabolic dysfunction. Statistical analyses were performed 
using SAS statistical software (version 9.3, Cary, NC). Statistical significance was 










A total of 100 children and adolescents participated in the research study. Table 1 
details participant demographics. Ages ranged from 8 – 17 years, with 61% aged 8 – 12 
and 39% aged 13 – 17. Every participant had BMI > 95th percentile, with absolute values 
ranging from 10.2 – 47.7 kg/m2. Females comprised over half of the sample (54%,          
n = 54). All races and ethnicities were included; however, the cohort was predominantly 
Hispanic (54%, n = 54) and non-Hispanic White (33%, n = 33). 
Table 2 depicts the average scores of metabolic dysfunction markers and A/L 
ratio in the cohort. With respect to the cutoffs for metabolic dysfunction markers in 
youth, the average measurement of triglycerides (126.4 ± 69.5 mg/dL), HOMA-IR       
(4.7 ± 3.5), and waist to hip ratio (0.63 ± 0.08) in this cohort exceeded the cutoffs for the 
normal range of measurements (see methods). Means of HDL, LDL, and blood pressure  
 








Mean ± SD* 28.8 ± 6.1 
Gender (%) 
Male 46.0 (n = 46) 
Female 54.0 (n = 54) 
Ethnicity (%) 
Hispanic 54.0 (n = 54) 
White, Non-Hispanic 33.0 (n = 33) 
Other/No Response 13.0 (n = 13) 
*SD = Standard Deviation 
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Table 2 
Average Values of Metabolic Dysfunction Markers 
 
Metabolic Marker   Mean ± SD* 
HDL (mg/dL)     46.4 ± 10.6 
LDL (mg/dL)     94.2 ± 20.7 
Triglycerides (mg/dL)   126.4 ± 69.5 
Systolic Blood Pressure (mmHg)   111.6 ± 11.5 
Diastolic Blood Pressure (mmHg)   66.8 ± 8.2 
Systolic Blood Pressure Percentile (%)     58.5 ± 27.5 
Diastolic Blood Pressure Percentile (%)     59.6 ± 24.2 
HOMA-IR     4.7 ± 3.5 
WHR     0.63 ± 0.08 
A/L Ratio     0.4 ± 0.7 
*SD = Standard Deviation 
 
were within the suggested range for children and adolescents. The mean A/L ratio was 
0.4 ± 0.7. 
Parents, or legal guardians, of all 100 participants completed breastfeeding 
questions during the baseline assessment. Of these 100 subjects, 82 (82%) were breastfed 
as infants. Parents of study participants also reported the total length of time the child was 
breastfed (from 1 week to ≥ 12 months), along with the length of time spent exclusively 
breastfeeding (from 1 week to ≥ 6 months). The average total time spent breastfeeding in 
infancy for these individuals was 8.3 months; the average time spent exclusively 
breastfeeding was 3.7 months. Table 3 outlines participant responses to the NHANES 
breastfeeding duration questions. A breastfeeding duration of 6 months or greater was 
seen in 66% (n = 54) of participants who were breastfed. Exclusive breastfeeding for at 
least 3 months was reported in 62% (n = 51) of participants, but fell to 34% (n = 28) at 6 



















   
< 3 Months 14 (17%) 7.2 ± 2.6 43.1 ± 33.3 0.33 ± 0.37 
3 to < 6 Months 14 (17%) 5.4 ± 2.6 26.7 ± 22.6 0.63 ± 1.14 





   
< 3 Months 27 (35%) 6.9 ± 2.5 49.8 ± 41.3 0.32 ± 0.44 
3 to < 6 Months 23 (29%) 6.3 ± 3.5 47.9 ± 47.8 0.52 ± 0.96 
≥ 6 Months 28 (36%) 7.2 ± 4.2 31.8 ± 21.4 0.47 ± 0.74 
 
Table 3 also summarizes the average corresponding adiponectin, leptin, and A/L 
ratio of different durations of total and exclusive breastfeeding times in the participants (4 
parents could not recall duration of exclusive breastfeeding). In the analysis, 
breastfeeding duration was split into 7 groups; “not breastfed” and 3 groups within total 
and exclusive breastfeeding time subcategories that included: > 0 to < 3 months, ≥ 3 
months to < 6 months, and ≥ 6 months. The average A/L ratio was 0.31 for those who 
were never breastfed and 0.43 for those who were breastfed for any amount of time; 
however, this difference was not statistically significant. When the means of adiponectin, 
leptin and A/L ratio were compared using Fisher’s F-test, there was no difference due to 
total breastfeeding time or exclusive breastfeeding duration in this population. There 
were no statistically significant differences due to gender or ethnicity in breastfeeding 
duration, adiponectin, leptin, or A/L ratio. 
Breastfeeding duration was also compared to metabolic dysfunction. A total of 86 
participants had complete metabolic measurements, and were thus included in the 
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analysis. Metabolic dysfunction was defined as ≥ 3 abnormal measures of HDL, LDL, 
triglycerides, blood pressure, HOMA-IR, and WHR. Presence of metabolic dysfunction 
(with ≥ 3 abnormal measures) was not associated with breastfeeding, total breastfeeding 
duration, or exclusive breastfeeding duration using Chi-square tests. There was also no 
association between breastfeeding, total breastfeeding duration, or exclusive 
breastfeeding duration and the presence of ≥ 4 abnormal metabolic measures. A summary 
of metabolic dysfunction presence can be found in Table 4, with both the number of 
participants in each category, along with the proportion of each group that qualified as 
having metabolic dysfunction. 
Regarding breakfast consumption, a total of 46 breakfast frequency responses 
were obtained during data collection from study participants (n =100). Table 5 
summarizes breakfast consumption responses and the average corresponding A/L ratio. 
Of the 46 subjects who answered the question on breakfast intake, only 9% (n = 4) stated  
 
Table 4 
Breastfeeding and Presence of Metabolic Dysfunction* 
 
Breastfeeding Duration 
(number of participants) 
≥ 3 Abnormal Values 
 
≥ 4 Abnormal Values 
 
Not Breastfed (n = 18) 33% 17% 
Total Breastfeeding (n = 
82) 
  
< 3 Months (n = 14) 36% 14% 
3 to < 6 Months (n = 14) 36%  7% 
≥ 6 Months (n = 54) 39% 11% 
Exclusive Breastfeeding (n = 78)  
< 3 Months (n = 27) 39% 13% 
3 to < 6 Months (n = 23) 30%  4% 
 ≥ 6 Months (n = 28) 43% 14% 
No differences between breastfeeding groups 
*Metabolic dysfunction includes HDL, LDL, triglycerides, blood pressure, HOMA-IR, 














0 Days 4 5.3 ± 2.2 53.3 ± 52.3 0.18 ± 0.19 
1 Day 1 2.0 14.9 0.13 
2 Days 0 - - - 
3 Days 1 7.8 16.7 0.47 
4 Days 3 9.5 ± 2.7     15.6 ± 3.4 0.65 ± 0.34 
5 Days 5 7.9 ± 1.8     24.5 ± 13.3 1.08 ± 1.79 
6 Days 5 8.4 ± 5.1     15.6 ± 11.1 0.74 ± 0.71 
7 Days 27 6.4 ± 2.5     34.1 ± 32.4 0.32 ± 0.28 
 
that they do not consume breakfast. The majority of participants (59%, n = 27) reported 
consuming breakfast every day. Average breakfast consumption was 5.6 days per week 
for these 46 individuals. Corresponding adiponectin, leptin, and A/L ratio were obtained 
for 45 of those who reported breakfast consumption. 
The groups with the lowest A/L ratio were those who reported consuming 
breakfast 1 day a week (A/L of 0.13) or no breakfast at all (A/L of 0.18 ± 0.19); the 
highest average A/L ratios were seen in the groups consuming breakfast 5 or 6 times 
weekly (1.08 ± 1.79 and 0.74 ± 0.71, respectively), although there was a large standard 
deviation and these differences were not statistically significant. Analyses of breakfast 
consumption and A/L ratio were conducted using a generalized linear model with 
breakfast as a categorical predictor and as a continuous predictor. When F-tests were 
applied to test for differences in A/L ratio and leptin concentration between different 
breakfast frequencies, treating days of breakfast consumption as a categorical variable 
and after controlling for gender, there was a significant difference (p = 0.02 and               
p = 0.009, respectively). In addition, there was a significant difference in BMI between 
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different breakfast intakes (p = 0.02); those consuming breakfast 3 – 5 days per week had 
a lower BMI (24.4 kg/m
2
) than those who consume less breakfast (0 – 1 times per week, 
32.7 kg/m
2
) and the most breakfast (6 – 7 times per week, 27.2 kg/m2). However, these 
differences did not persist when breakfast consumption was treated as a linear predictor. 
With breakfast as a linear predictor, there was a relationship between breakfast frequency 
and A/L ratio, when controlling for ethnicity (p = 0.05). There were no significant 
differences in adiponectin, leptin, or A/L ratio with increasing amounts of breakfast 
consumption in the study population (Table 5). 
Metabolic dysfunction was also measured in relation to breakfast intake (Table 6). 
Of the 46 breakfast responders, 33 had complete metabolic dysfunction measurements. 
Chi-square tests revealed no association between the presence of metabolic dysfunction 
(with ≥ 3 abnormal measures) and the amount of weekly breakfast consumption. There 
was also no association between breakfast intake and the presence of ≥ 4 abnormal 
metabolic measures. A summary of metabolic dysfunction can be found in Table 6, with  
 
Table 6 
Breakfast Consumption and the Presence of Metabolic Dysfunction* 
 
Breakfast Frequency,    
days/week 
(number of participants) 
≥ 3 Abnormal Values 
 
≥ 4 Abnormal Values 
 
0 Days (n = 4)  25%  25% 
1 Day  (n = 1) 0 0 
2 Days (n = 0) - - 
3 Days (n = 1) 100% 100% 
4 Days (n = 3)  33% 0 
5 Days (n = 5)  40% 0 
6 Days (n = 5)  20% 0 
7 Days (n = 27)  37%  11% 
*Metabolic dysfunction includes HDL, LDL, triglycerides, blood pressure, HOMA-IR, 
WHR   
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both the number of participants in each category, along with the proportion of each 
breakfast group that qualified as having metabolic dysfunction. 
Finally, logistic regression was applied to predict the presence of metabolic 
dysfunction using A/L ratio as a predictor. Using Chi-square tests, there was no 
significant relationship between A/L ratio and metabolic dysfunction as defined as ≥ 3 
abnormal values, or as ≥ 4 abnormal values. The effects due to gender and ethnicity were 
unclear through the logistic regression analysis, due to a sample size that was too small 











This study investigated the effect of diet, specifically breastfeeding and breakfast, 
on A/L ratio and metabolic dysfunction in obese youth. Additional analyses between A/L 
ratio and the presence of metabolic dysfunction were also performed. Statistical tests 
revealed no association between the length of total or exclusive breastfeeding in infancy 
and alterations in A/L ratio or the presence of metabolic dysfunction in childhood and 
adolescence. Similarly, a greater frequency of breakfast intake was not predictive of 
alterations in A/L ratio or metabolic dysfunction. A/L ratio was not associated with the 
presence of metabolic dysfunction as well.  
 There were no statistically significant differences due to gender or ethnicity in the 
relationship between breastfeeding duration, adiponectin, leptin, and A/L ratio. In 
addition, there were no statistically significant differences in BMI among breastfeeding 
groups. There were however, differences due to gender and ethnicity in comparisons of 
breakfast intake, leptin, and A/L ratio, as well as differences in BMI among different 
breakfast frequencies. When breakfast intake was examined categorically, differences 
were observed in BMI across the various frequencies of breakfast consumption, with the 
lowest BMI in those consuming breakfast 3-5 times per week (24.4 kg/m
2
) (p = 0.02). 
Differences were also observed in A/L ratio (p = 0.02) and leptin (p = 0.009) across the 
possible breakfast intakes when gender was controlled for. These categorical associations 
disappeared when breakfast frequency was treated as a quantitative variable in a general 
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linear model. In the analysis of breakfast intake as a linear model, there were no 
statistically significant associations. Of interest, however, is a relationship between 
breakfast frequency and A/L ratio when ethnicity was controlled for (p = 0.05).  
 The observed results do not support studies that suggest breastfeeding and 
breakfast consumption offer a benefit to metabolic health. Current research proposes that 
a history of being breastfed may promote a lower cholesterol, BMI (4, 33), and blood 
pressure (33). However, with no statistically significant relationship found between 
breastfeeding and metabolic dysfunction, the present study agrees instead with Parikh et 
al. and Rudnicka et al. who found no association between breastfeeding and HDL (40, 
45), LDL, triglycerides, and blood pressure (45). Participants in current research of 
metabolic dysfunction and breastfeeding history tend to be adults, not a population of 
obese children and adolescents, which may explain the differences observed. Differences 
in the present study may also be explained by variations in weight of the sample 
population, as breastfeeding has previously been associated with a decreased prevalence 
of overweight and obesity (34, 35, 36).  
 Similar to breastfeeding, results detailing breakfast consumption in relation to 
metabolic dysfunction did not reflect findings of current literature. Skipping breakfast has 
been associated with components of metabolic dysfunction that include an increased 
LDL, fasting insulin, and waist circumference, as well as decreased HDL (37, 38). 
Specifically in children, skipping breakfast is associated with higher triglycerides and 
fasting glucose (39). The present study did not measure trends of breakfast frequency in 
relation to individual metabolic factors; instead, the outcome of interest was the presence 
of a minimum number of abnormal values to qualify as metabolic dysfunction. Although 
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results are inconsistent with the literature, a comparison of individual factors to a sum of 
factors is likely a contributing cause to the discrepancy. Another explanation for the 
results could include participant responses to the breakfast frequency question – most 
individuals reported regular consumption of breakfast all days of the week. With few 
respondents of other frequencies, comparisons of groups were limited. A lack of 
significant findings may also be explained by the narrow research question, as the type of 
breakfast consumed may impact metabolic dysfunction more than frequency alone. A 
study by Deshmukh-Taskar et al. found that while breakfast consumption in general 
provided benefits in cholesterol levels, the consumption of ready to eat cereals (rather 
than other types of breakfast) was associated with additional benefits in weight and blood 
pressure (38). 
In addition to diet, research suggests a relationship between metabolic 
dysfunction and the A/L ratio as well as adiponectin levels. Higher adiponectin is 
associated with many metabolic benefits including improved HDL, triglycerides, systolic 
blood pressure, and WHR in adolescents (16); low A/L ratio is associated with metabolic 
syndrome (24, 25, 26, 27) and insulin resistance (25, 27, 28, 29). However, this was not 
seen in the study results. The present study found no relationship between A/L ratio and 
metabolic dysfunction in obese youth. The associations observed with metabolic 
dysfunction were witnessed in adult populations, not a cohort of obese youth. 
Furthermore, puberty is a time of hormonal change, and adiponectin and leptin levels 
have been noted to differ with age during this period, potentially skewing results (59).  
Associations between A/L ratio and breastfeeding history or breakfast intake in 
literature are less clear. Although research suggests that adiponectin may be influenced 
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by diet, no studies have investigated A/L (or adiponectin) in relation to breastfeeding 
history or breakfast habits in children or adolescents. One study by English et al. found 
that the consumption of an early meal helped normalize serum adiponectin levels in 
obese adults for at least 3 hours (52). Nevertheless, conclusions were drawn from 
nonfasting measurements of adiponectin and the results reflected short term levels of the 
adipokine. Current literature may, however, offer an explanation for the association 
between A/L ratio and categorical levels of breakfast intake between genders. A study by 
Mirza et al. found significant differences in adiponectin and leptin between males and 
females, similar to results found in this study (24). The observations in this case would be 
due to varying levels of adipokines between genders. 
Research is lacking in the comparison of diet, A/L ratio, and metabolic 
dysfunction. Fewer studies exist in this research area that examine a population of obese 
children and adolescents. Particular attention to this population is critical at this point in 
time, with the high rates of pediatric obesity and associated metabolic consequences in 
the United States. Additional explorations are needed to expand the knowledge base of 
metabolic dysfunction and diet in this group. Specifically, additional research on 
breakfast and metabolic health, expanding upon frequency to include type and amount of 
breakfast consumed, is recommended.  
 
Strengths and Limitations 
Strengths of the study include the use of validated nutrition questions and a 
targeted sample of obese children and adolescents. Other strengths include a unique 
research topic with a study cohort that has not been investigated extensively in literature. 
Although results were statistically insignificant, the current study on the effects of diet on 
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metabolic dysfunction in youth suggests a new area of research in the quest for greater 
understanding of obesity and metabolic disease in children. This study also focused on 
specific dietary factors (breastfeeding in infancy and breakfast consumption), rather than 
a generalized healthful diet, as a more applicable potential method in the treatment and 
prevention of childhood obesity.  
The study was limited by the use of questionnaires, rather than researcher 
observation or diet records, to assess diet. The reporting of breastfeeding history was a 
limitation, requiring parents to recall details of a behavior that was practiced a minimum 
of 7 years prior to the data collection. Breastfeeding history was a greater disadvantage to 
participants who were adopted, as the adoptive parents may not know details of the 
child’s perinatal nutrition. Furthermore, during the data collection appointment, 
participants and their parents recalled the frequency of consumption of breakfast over the 
previous year. Accuracy of data was dependent on either the child correctly recalling 
intake, or the parent having complete knowledge of the diet.  
Another limitation was the narrow target population of obese children and 
adolescents in Salt Lake County. This study population was not representative of obese 
children and adolescents in the United States, as the sample population consisted of 
mostly Hispanic and non-Hispanic individuals. Other limitations included the omission of 
nutrition questions during some data collection visits (requiring a follow up phone call or 
email), participant refusal of the blood draw and an inability to recruit the goal of 220 
volunteers. Transportation to the data collection site during school and working hours 
was also a barrier to some families, as was transportation during inclement winter 
weather, thus limiting participation.  
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The analyses were limited by the lack of socioeconomic status and parent 
education level reporting. These two factors may play a role in the decision of a parent to 
breastfeed or not, and may influence overall diet and potentially the A/L ratio. Those 
mothers who breastfed longer may understand the role of child nutrition in growth, and 




 Results of this study do not support an association between metabolic dysfunction 
and the dietary factors of breastfeeding in infancy and frequent breakfast intake in obese 
children and adolescents. In addition, A/L ratio was not associated with either metabolic 
dysfunction or the diet habits of interest in the study population. A comparison of 
increasing breakfast intake and A/L ratio revealed an interesting association when 
ethnicity was observed, which was not statistically significant. Further investigation into 
this trend is warranted, as well as continued investigations into the relationship between 
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